BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 29779309)

  • 1. [The survival prediction model of advanced gallbladder cancer based on Bayesian network: a multi-institutional study].
    Tang ZH; Geng ZM; Chen C; Si SB; Cai ZQ; Song TQ; Gong P; Jiang L; Qiu YH; He Y; Zhai WL; Li SP; Zhang YC; Yang Y
    Zhonghua Wai Ke Za Zhi; 2018 May; 56(5):342-349. PubMed ID: 29779309
    [No Abstract]   [Full Text] [Related]  

  • 2. Estimating survival benefit of adjuvant therapy based on a Bayesian network prediction model in curatively resected advanced gallbladder adenocarcinoma.
    Geng ZM; Cai ZQ; Zhang Z; Tang ZH; Xue F; Chen C; Zhang D; Li Q; Zhang R; Li WZ; Wang L; Si SB
    World J Gastroenterol; 2019 Oct; 25(37):5655-5666. PubMed ID: 31602165
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Analysis of the relationship between the number of lymph nodes examined and prognosis for curatively resected gallbladder carcinoma: a multi-institutional study].
    Zhang R; Wu YH; Zhang D; Zhang YJ; Qiu YH; Yang N; Song TQ; Lou JY; Li JT; Mao XH; Li SP; Si SB; Cai ZQ; Chen C; Geng ZM; Tang ZH
    Zhonghua Wai Ke Za Zhi; 2020 Apr; 58(4):303-309. PubMed ID: 32241061
    [No Abstract]   [Full Text] [Related]  

  • 4. Survival prediction for gallbladder carcinoma after curative resection: Comparison of nomogram and Bayesian network models.
    Wu Y; Li Q; Cai Z; Zhang Y; Qiu Y; Yang N; Song T; Li S; Lou J; Li J; Mao X; Chen C; Zhang D; Si S; Geng Z; Tang Z
    Eur J Surg Oncol; 2020 Nov; 46(11):2106-2113. PubMed ID: 32807616
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Application value of different lymph node staging system in predicting prognosis of patients with intrahepatic cholangiocarcinoma].
    Chen C; Wu YH; Li Q; Wu H; Qiu YH; Song TQ; Mao XH; He Y; Cheng Z; Zhai WL; Li JD; Geng ZM; Tang ZH
    Zhonghua Wai Ke Za Zhi; 2020 Apr; 58(4):295-302. PubMed ID: 32241060
    [No Abstract]   [Full Text] [Related]  

  • 6. Nomogram to predict overall survival after gallbladder cancer resection in China.
    Bai Y; Liu ZS; Xiong JP; Xu WY; Lin JZ; Long JY; Miao F; Huang HC; Wan XS; Zhao HT
    World J Gastroenterol; 2018 Dec; 24(45):5167-5178. PubMed ID: 30568393
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimal Lymph Node Staging System in Evaluating Prognosis of Gallbladder Carcinoma: A Multi-institutional Study.
    Chen C; Rui Z; Yuhan W; Yongjie Z; Yinghe Q; Ning Y; Tianqiang S; Jianying L; Jiangtao L; Xianhai M; Shengping L; Shubin S; Zhiqiang C; Zhaohui T; Zhimin G
    Ann Surg Oncol; 2021 Dec; 28(13):8142-8151. PubMed ID: 34532819
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-Term Outcomes and Prognostic Factors in Advanced Gallbladder Cancer: Focus on the Advanced T Stage.
    Chen C; Geng Z; Shen H; Song H; Zhao Y; Zhang G; Li W; Ma L; Wang L
    PLoS One; 2016; 11(11):e0166361. PubMed ID: 27846279
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decision of surgical approach for advanced gallbladder adenocarcinoma based on a Bayesian network.
    Cong LL; Cai ZQ; Guo P; Chen C; Liu DC; Li WZ; Wang L; Zhao Y; Si SB; Geng ZM
    J Surg Oncol; 2017 Dec; 116(8):1123-1131. PubMed ID: 28876457
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pilot study of the relationship between clinical classification of gallbladder cancer and prognosis: a retrospective multicenter clinical study].
    Zhang D; Geng ZM; Chen C; Zhang YJ; Qiu YH; Yang N; Wang DS; Wang XZ; Song TQ; Lou JY; Li JT; Mao XH; Duan WB; Li SP; Lao XM; Zhao XQ; Chen YJ; Zhang L; Qiu YD; Liu YY; Zeng W; Gong ZH; Tang JS; Liu QG; Quan ZW
    Zhonghua Wai Ke Za Zhi; 2019 Apr; 57(4):258-264. PubMed ID: 30929370
    [No Abstract]   [Full Text] [Related]  

  • 11. [The impact of modified T3 sub-staging on the prognosis of gallbladder cancer patients].
    Chen C; Zhang D; Li Q; Lei JJ; Geng ZM
    Zhonghua Wai Ke Za Zhi; 2024 Apr; 62(4):302-308. PubMed ID: 38432671
    [No Abstract]   [Full Text] [Related]  

  • 12. [A prognostic model of intrahepatic cholangiocarcinoma after curative intent resection based on Bayesian network].
    Chen C; Wu YH; Zhang JW; Qiu YH; Wu H; Li Q; Song TQ; He Y; Mao XH; Zhai WL; Cheng ZJ; Li JD; Si SB; Cai ZQ; Geng ZM; Tang ZH
    Zhonghua Wai Ke Za Zhi; 2021 Apr; 59(4):265-271. PubMed ID: 33706443
    [No Abstract]   [Full Text] [Related]  

  • 13. Analysis of prognostic factors for survival after surgery for gallbladder cancer based on a Bayesian network.
    Cai ZQ; Guo P; Si SB; Geng ZM; Chen C; Cong LL
    Sci Rep; 2017 Mar; 7(1):293. PubMed ID: 28331235
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Impact of adjuvant chemotherapy on prognosis in intrahepatic cholangiocarcinoma patients underwent radical resection].
    Su JB; Zhang JW; Chen C; Qiu YH; Wu H; Song TQ; He Y; Mao XH; Zhai WL; Cheng ZJ; Li JD; Si SB; Cai ZQ; Geng ZM; Tang Z
    Zhonghua Wai Ke Za Zhi; 2022 Apr; 60(4):356-362. PubMed ID: 35272427
    [No Abstract]   [Full Text] [Related]  

  • 15. Efficacy of the Gallbladder Cancer Predictive Risk Score Based on Pathological Findings: A Propensity Score-Matched Analysis.
    Mochizuki T; Abe T; Amano H; Hanada K; Hattori M; Kobayashi T; Nakahara M; Ohdan H; Noriyuki T
    Ann Surg Oncol; 2018 Jun; 25(6):1699-1708. PubMed ID: 29626304
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Managing the incidentally detected gallbladder cancer: algorithms and controversies.
    Cavallaro A; Piccolo G; Di Vita M; Zanghì A; Cardì F; Di Mattia P; Barbera G; Borzì L; Panebianco V; Di Carlo I; Cavallaro M; Cappellani A
    Int J Surg; 2014; 12 Suppl 2():S108-S119. PubMed ID: 25182380
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The prognosis after curative resection of gallbladder cancer with hilar invasion is similar to that of hilar cholangiocarcinoma.
    Nasu Y; Tanaka E; Hirano S; Tsuchikawa T; Kato K; Matsumoto J; Shichinohe T; Kondo S
    J Hepatobiliary Pancreat Sci; 2012 May; 19(3):274-80. PubMed ID: 21879321
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carcinoma of the gallbladder: patterns of presentation, prognostic factors and survival rate. An 11-year single centre experience.
    D'Hondt M; Lapointe R; Benamira Z; Pottel H; Plasse M; Letourneau R; Roy A; Dagenais M; Vandenbroucke-Menu F
    Eur J Surg Oncol; 2013 Jun; 39(6):548-53. PubMed ID: 23522952
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Efficacy analysis of surgical combined with postoperative adjuvant therapy for T3 gallbladder carcinoma: a multicenter retrospective study].
    Yang FC; Hu J; Su TH; Geng ZM; Zhang K; Ding J; Lei ZQ; Yi B; Li JD; Tang ZH; Cheng ZJ; Qiu YH
    Zhonghua Wai Ke Za Zhi; 2023 Oct; 61(10):863-870. PubMed ID: 37653988
    [No Abstract]   [Full Text] [Related]  

  • 20. [The progress on survival prediction model of gallbladder carcinoma].
    Geng ZM; Li Q; Zhang Z; Si SB; Cai ZQ; Zhao YL; Tang ZH
    Zhonghua Wai Ke Za Zhi; 2020 Aug; 58(8):649-652. PubMed ID: 32727199
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.